ZTE
ZTE, a leading global mobile device maker, today began to showcase a range of smart devices at Mobile World Congress 2015 that are soon to be launched in markets across Europe. Flagship products on show include the smart voice ZTE Star 2, Smart Sense ZTE Blade S6, and the innovative Spro 2, the only smart projector with a touchscreen Android operating system.
“We are very excited to confirm the upcoming European availability for several of our hottest new products,” said Kan Yulun, CEO of EMEA & LATAM, ZTE Mobile Devices, and Vice President of ZTE Corporation. “We will continue to bring our latest smartphones to markets across Europe, as well as other smart connected devices such as our Spro 2 smart projector.”
With optimized system-level voice control, the ZTE Star 2 on show at MWC 2015 has been upgraded to feature English-language GPS and speech-to-text input that supports British English. ZTE’s Star 2 is set to launch in Germany at CeBIT on 12 March 2015. At present, voice control functions that support Spanish are under development, which will be the third smart voice language available after Chinese and English.
The ZTE Blade S6, which features ZTE’s innovative Smart Sense - an intuitive and practical set of gesture and motion controls - will soon be launched offline via channel partners in Germany, Spain, and France at the end of the month. This follows recent online launches via AliExpress globally, as well as via eBay and Amazon for the United Kingdom, Germany, France, Italy and Spain. Outside Europe, the ZTE Blade S6 is also set for offline launches in Malaysia, Thailand, Russia and other markets across the Asia Pacific. The ZTE Blade L3 was also on display at ZTE’s booth, a device aimed at the budget shopper and younger smartphone user, which is also destined for European launches in April 2015. Devices in the Blade series underscore ZTE’s commitment to offering premium smartphones at affordable prices.
Unlike any other smart projector, the Spro 2 features a touchscreen Android operating system that provides full access to the Google Play store and a mobile hotspot. The smart projector was revealed at the 2015 Consumer Electronics Show and received four prestigious awards. The Spro 2 will be available later this year in the United States through wireless carriers and across European markets.
ZTE’s MWC 2015 smartphone line-up also included the iF DESIGN AWARD 2015 winner, ZTE Grand S3 with Eyeprint ID, as well as the ZTE Open L – one of the first LTE smartphones to ship with the latest version of Firefox OS 2.2. In addition to smartphones, other technology on display included the ZTE Sports Camera and ZTE in-house LTE chipsets.
About ZTE Mobile Devices
ZTE Mobile Devices is a division of ZTE Corporation, a global telecommunications equipment, networks and mobile devices company headquartered in Shenzhen, China. ZTE is a publicly traded company listed on the Hong Kong and Shenzhen stock exchanges.
ZTE is one of the global leaders in the mobile handset manufacturing industry in the world, offering a complete range of mobile devices, including mobile phones, tablets, mobile broadband modems and hotspots and family desktop integration terminals.
ZTE has strategic partnerships with 47 of the world’s top 50 carriers. Additionally, ZTE ranked No.1 in PCT patent applications according to the WIPO (World Intellectual Property Organization) in 2011 and 2012. For more information, please visit: www.ztedevice.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150301005211/en/
Contact:
Media Contacts:
ZTE Corporation
Eva Chen, +86 21
68897511
chen.zhengying@zte.com.cn
or
Waggener
Edstrom Communications
Laura Liu, +86 10 59001242
laural@waggeneredstrom.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum